Wieland Douglas Scott 4
4 · CYTRX CORP · Filed Dec 14, 2009
Insider Transaction Report
Form 4
CYTRX CORPCYTR
Wieland Douglas Scott
Sr. VP - Drug Development
Transactions
- Award
Stock Option (right to buy)
2009-12-10+100,000→ 100,000 totalExercise: $1.05Exp: 2019-12-09→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Stock Option vests monthly for 36 months beginning January 10, 2010, provided Reporting Person remains in continuous employ of Issuer.